✦ LIBER ✦

Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

✍ Scribed by Stein, Alexander; Petersen, Volker; Schulze, Mathias; Seraphin, Jörg; Hoeffkes, Heinz-Gert; Valdix, Anette R.; Schroeder, Jan; Herrenberger, Julia; Boxberger, Frank; Leutgeb, Barbara; Hinke, Axel; Kutscheidt, Andreas; Arnold, Dirk

Book ID: 126665403
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 406 KB
Volume: 54
Category: Article
ISSN: 0284-186X
DOI: 10.3109/0284186X.2014.961649

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gastrointestinal perforation associated

Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: Results from a large treatment observational cohort study

✍ Fairooz F. Kabbinavar; Patrick J. Flynn; Mark Kozloff; Mark A. Ashby; Amy Sing; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Bevacizumab Beyond First Progression Is

Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)

✍ Grothey, A.; Sugrue, M. M.; Purdie, D. M.; Dong, W.; Sargent, D.; Hedrick, E.; K 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 227 KB

FOLFIRI plus bevacizumab as a first-line

FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study

✍ Kochi, Mitsugu; Akiyama, Yuji; Aoki, Tatsuya; Hagiwara, Ken; Takahashi, Takao; H 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 453 KB

Treatment Patterns and Clinical Outcomes

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study

✍ Bendell, J. C.; Bekaii-Saab, T. S.; Cohn, A. L.; Hurwitz, H. I.; Kozloff, M.; Te 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 495 KB

6074 Bevacizumab (bev) combined with che

6074 Bevacizumab (bev) combined with chemotherapy as 2nd-line treatment for metastatic colorectal cancer (mCRC): results from the phase II BEVACOLOR study

✍ Bennouna, J.; Husseini, F.; Delord, J.P.; Borg, C.; Trillet-Lenoir, V.; Faroux, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

6088 Safety and efficacy of bevacizumab

6088 Safety and efficacy of bevacizumab (BEV) and chemotherapy in elderly patients with metastatic colorectal cancer (mCRC): results from the BEAT observational cohort study

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB